HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury.

Abstract
Immune activation represents an adaptive reaction triggered by both noxious exogenous (microbes) and endogenous [high mobility group box-1 protein (HMGB1), S100 calcium binding proteins] inducers of inflammation. Cell stress or necrosis lead the release of HMGB1 and S100 proteins in the extracellular compartment where they act as damage-associated molecular pattern molecules (or alarmins) by engaging the receptor for advanced glycation end-products (RAGE). Although the biology of RAGE is dictated by the accumulation of damage-associated molecular pattern molecules at sites of tissue injury, the role of RAGE in mediating antenatal fetal injury remains unknown. First, we studied the relationships at birth between the intensity of human fetal inflammation and sRAGE (an endogenous RAGE antagonist), HMGB1, and S100beta protein. We found significantly lower sRAGE in human fetuses that mounted robust inflammatory responses. HMGB1 levels correlated significantly with levels of interleukin-6 and S100beta in fetal circulation. We then evaluated the levels and areas of tissue expression of RAGE, HMGB1, and S100beta in specific organs of mouse fetuses on E16. Using an animal model of endotoxin-induced fetal damage and preterm birth, we determined that inflammation induces a significant change in expression of RAGE and HMGB1, but not S100beta, at sites of tissue damage. Our findings indicate that RAGE and HMGB1 may be important mediators of cellular injury in fetuses delivered in the setting of inflammation-induced preterm birth.
AuthorsCatalin S Buhimschi, Margaret A Baumbusch, Antonette T Dulay, Emily A Oliver, Sarah Lee, Guomao Zhao, Vineet Bhandari, Richard A Ehrenkranz, Carl P Weiner, Joseph A Madri, Irina A Buhimschi
JournalThe American journal of pathology (Am J Pathol) Vol. 175 Issue 3 Pg. 958-75 (Sep 2009) ISSN: 1525-2191 [Electronic] United States
PMID19679874 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Endotoxins
  • Glycation End Products, Advanced
  • HMGB1 Protein
  • Interleukin-6
  • Nerve Growth Factors
  • S100 Calcium Binding Protein beta Subunit
  • S100 Proteins
Topics
  • Animals
  • Endotoxins (toxicity)
  • Female
  • Fetus (immunology, pathology)
  • Glycation End Products, Advanced (biosynthesis)
  • HMGB1 Protein (biosynthesis)
  • Humans
  • Inflammation (genetics)
  • Interleukin-6 (metabolism)
  • Mice
  • Necrosis
  • Nerve Growth Factors (biosynthesis)
  • Pregnancy
  • Premature Birth (chemically induced, immunology)
  • S100 Calcium Binding Protein beta Subunit
  • S100 Proteins (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: